Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Antimicrobial Agents|July 13, 2013
Daptomycin: the role of high-dose and combination therapy for Gram-positive infectionsIan M Gould, José M Miró, Michael J Rybak
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Calculation of composite recovery time: a new pharmacodynamic parameterFiona M MacKenzie, Kathleen E Milne, Ian M Gould
International Journal of Antimicrobial Agents|April 15, 2004
Reassessment of the cefaclor breakpoint for Streptococcus pneumoniaeFiona M MacKenzie, Kathleen E Milne, Ian M Gould
The Journal of Antimicrobial Chemotherapy|July 21, 2006
Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitalsFiona M MacKenzie, Dominique L Monnet, Ian M Gould, et al.
Drugs|April 12, 2019
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for StewardshipShio-Shin Jean, Ian M Gould, Wen-Sen Lee, et al.
International Journal of Antimicrobial Agents|July 2, 2017
Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the newMichael Z David, Matthew Dryden, Thomas Gottlieb, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE ScotlandFiona M MacKenzie, Paul Greig, Donald Morrison, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis PatientsIjeoma N Okoliegbe, Karolin Hijazi, Kim Cooper, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosaIjeoma N Okoliegbe, Karolin Hijazi, Kim Cooper, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2021
Trends of Antimicrobial Resistance and Combination Susceptibility Testing of Multidrug-Resistant Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients: a 10-Year UpdateIjeoma N Okoliegbe, Karolin Hijazi, Kim Cooper, et al.
Pageof 6